Stem cell therapy for the treatment of Leydig cell dysfunction in primary hypogonadism

doi:10.4252/wjsc.v8.i10.306

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9436)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

594

WORD

298

HTML

5987

Figures (1-2)

268

Tables (1-1)

196

Sum=7343

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1088

Download

1005

Sum=2093

Oct 26, 2016 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Therapeutic Advances

World J Stem Cells. Oct 26, 2016; 8(10): 306-315
Published online Oct 26, 2016. doi: 10.4252/wjsc.v8.i10.306

Full Size Figure Download Figure

Figure 1 Testosterone biosynthetic pathway. FSH: Follicle stimulating hormone; LH: Luteinizing hormone; HDL: High-density lipoprotein; StAR: Steroidogenic acute regulatory protein.

Citation: Peak TC, Haney NM, Wang W, DeLay KJ, Hellstrom WJ. Stem cell therapy for the treatment of Leydig cell dysfunction in primary hypogonadism. World J Stem Cells 2016; 8(10): 306-315
URL: https://www.wjgnet.com/1948-0210/full/v8/i10/306.htm
DOI: https://dx.doi.org/10.4252/wjsc.v8.i10.306